T
Tribun Health
Biotech & Life Sciences · Châtillon, France · Founded 2011
Digital pathology software and diagnostic imaging solutions MoreLess
Tribun Health, founded in 2016 by Jean-François Pomerol, is a company that specializes in the digital transformation of cancer diagnosis. The company provides software solutions for diagnostic laboratories and pharmaceutical/biotech companies, enabling them to manage, analyze, and share cellular images.
The company's core business revolves around its digital pathology platform. This platform incorporates artificial intelligence, specifically deep and machine learning algorithms, to assist physicians and researchers in diagnostic decision-making and scientific evaluation. The goal is to enhance the accuracy and efficiency of cancer diagnosis for the benefit of patients.
Tribun Health also offers web-based tools that support telepathology, remote teaching, and multi-center clinical validation activities. This facilitates collaboration among professionals in the field. The company provides customized support to ensure its solutions meet the specific needs of its clients.
Keywords: digital pathology, cancer diagnosis, image analysis, artificial intelligence, telepathology, clinical decision support, diagnostic software, biotech, cellular imaging, laboratory solutions
Company overview
Tribun Health company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2011
- Headquarters
- Châtillon, France
- Employees
- 54
- Open positions
- None listed
- Dealroom signal
- 66.1
Valuation & funding
Tribun Health funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| GRANTOther financing | Apr 2024 | $618K | — | Undisclosed | ↗ |
| SERIES B✓Equity / VC | Sep 2023 | $17M | $66M | Owkin · Vivalto Family · Bpifrance | ↗ |
| SUPPORT PROGRAM✓Other financing | Jun 2020 | $33K | — | EIT Health | — |
| EARLY VC✓Equity / VC | Jul 2019 | $5.5M | $22M | LBO France | ↗ |
Financials
Revenue, earnings and profit over time
Reported history and available estimates. Estimated years are marked “E”; sparse fields are left blank rather than inferred.
Growth signals
Tribun Health website traffic
Latest recorded traffic for Tribun Health is 360 monthly website visits, down 72.3% over the last three months. Tribun Health's team declined 12.9% over the past year.
Comparisons
Tribun Health compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Tribun Health's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Tribun Health has talent and traffic
team presence
In the news
Latest news about Tribun Health
Recent press, funding announcements, and product moves mentioning Tribun Health — open to read from the original sources.
Market sentiment
What the market is saying about Tribun Health
An AI-synthesized read of the highest-engagement posts about Tribun Health on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Tribun Health’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.